Elisabetta Mantengoli

Elisabetta Mantengoli

Auto-generated profile, based on publicly available information

Elisabetta Mantengoli

Infectious and Tropical Diseases Unit Azienda Ospedaliero‐Universitaria Careggi Florence Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
ETEvelina Tacconelli
Evelina Tacconelli
MCMaria Adriana Cataldo
Maria Adriana Cataldo
NMNico T Mutters
Nico T Mutters
ECElena Carrara
Elena Carrara
Alessandro BartoloniAlessandro Bartoloni
Alessandro Bartoloni
Gian Maria RossoliniGian Maria Rossolini
Gian Maria Rossolini

13 January 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CBChiara Della Bella
Chiara Della Bella
ACAlberto Corrà
Alberto Corrà
EMElisabetta Mantengoli
Elisabetta Mantengoli
AGAngelo Galano
Angelo Galano
MBMarisa Benagiano
Marisa Benagiano
MCMarzia Caproni
Marzia Caproni

3 February 2025 in The Journal of Dermatology
Verified
Journal Article
Open access
DBD. Bonciani
D. Bonciani
CBC. Della Bella
C. Della Bella
ACAlberto Corrà
Alberto Corrà
AGA. Galano
A. Galano
GVG. Vaggelli
G. Vaggelli
MCMarzia Caproni
Marzia Caproni
The association between psoriasis and streptococcal infection has been widely explored in both children and adults. However, the exact impact of Streptococcus pharyngeal infection on the course of psoriasis is not fully comprehended. This study explored the impact of Streptococcus pharyngeal infection on psoriasis and investigated the effectiveness of systemic antibiotic therapy in conjunction with standard topical treatment for psoriatic patients with concomitant streptococcal throat infection. The research involved 115 patients with mild‐to‐moderate psoriasis, clinically assessed using the Psoriasis Area and Severity Index (PASI). Patients with active streptococcal infection were administered adjunctive systemic antibiotic therapy along with standard local treatment for psoriasis, while psoriasis patients without evidence of infection received the local topical treatment only. Streptococcal infections were more common in psoriasis patients compared to healthy controls. A group of psoriasis patients with active streptococcal throat infections, treated with antibiotics in addition to standard topical psoriasis therapy, did not show any difference in PASI score reduction compared to those without evidence of active infection. While our study did not show a statistically significant reduction in PASI scores in psoriasis patients with streptococcal throat infections treated with antibiotics, it highlights the complex interaction between infection and psoriasis. Larger studies with longer follow‐up may better clarify this relationship, contributing to stronger evidence for or against the use of antibiotics in managing psoriasis triggered by streptococcal infections.